Dual Antiplatelet Duration Following Percutaneous Coronary Intervention: Is it Time to aDAPT?
This is a recording of a live continuing education program provided by one of our PGY2 Cardiology Pharmacy Residents, Dr. Alina Kukin in September 2019.
Please note that the polling was closed after the session so the results in the recording are reflective of the audience during that presentation only.
Видео Dual Antiplatelet Duration Following Percutaneous Coronary Intervention: Is it Time to aDAPT? канала ATRIUM Collaborative
Please note that the polling was closed after the session so the results in the recording are reflective of the audience during that presentation only.
Видео Dual Antiplatelet Duration Following Percutaneous Coronary Intervention: Is it Time to aDAPT? канала ATRIUM Collaborative
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Throwback Thursday: CAST Trial
A Focus Series on Hypertension: Calcium Channel Blockers
Weighing the Evidence: Direct Oral Anticoagulant Use in Obese Patients
Throwback Thursday: TRITON-TIMI 38 and TRILOGY ACS trials
New Cardiac Medications - Will They Fill a Gap in Care?
Optimizing Guideline-Directed Medical Therapy in HFrEF: Beta-Blockers
A Focus Series on Hypertension: Complications
Drug Induced Hypertension
A Focus Series on Hypertension: Diagnosis and Severity
Role of Pharmacists in Preventing Heart Failure Readmissions
University of Maryland Cardiology Pharmacy Residency Overview
A Focus Series on Hypertension: Therapeutic Objectives
Getting to the Heart of the Patient Interview: Tips for Interviewing Patients with Heart Faiure
Blood Pressure Goals in Patients with Cardiovascular Disease
Playing the Oldies but Goodies for the Treatment of Resistant Hypertension
A Focus Series on Hypertension: Monitoring
A Focus Series on Hypertension: Treatment Resistant Hypertension
Updates in the Management of Pericarditis
Bring the Beat In: The Increasing Role of Rhythm Control in Atrial Fibrillation
Management of acute gout in patients with heart failure